{"id":570009,"date":"2021-10-20T18:56:02","date_gmt":"2021-10-20T18:56:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=570009"},"modified":"2021-10-20T18:56:02","modified_gmt":"2021-10-20T18:56:02","slug":"singleuse-bioreactors-market-worth-88-billion-by-2026-key-players-are-sartorius-stedim-biotech-france-thermo-fisher-scientific-us","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/singleuse-bioreactors-market-worth-88-billion-by-2026-key-players-are-sartorius-stedim-biotech-france-thermo-fisher-scientific-us_570009.html","title":{"rendered":"Single-use Bioreactors Market worth $8.8 billion by 2026 – Key Players are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US)"},"content":{"rendered":"
\n
\"Single-use<\/a><\/div>\n
\n
Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the single-use bioreactors market.<\/div>\n<\/div>\n<\/div>\n
Single-use Bioreactors Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow.<\/div>\n

According to the new market research report “<\/strong>Single-use Bioreactors Market<\/a> by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) – Global Forecast to 2026″<\/strong>, published by MarketsandMarkets™, the global Single-Use Bioreactors Market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period.<\/p>\n

Browse in-depth TOC on <\/em>“Single-use Bioreactors Market”<\/strong><\/p>\n

235 – Tables<\/strong>
32 – Figures<\/strong>
207 – Pages<\/strong><\/strong><\/p>\n

Download PDF Brochure: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=49113750<\/a><\/p>\n

Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.<\/p>\n

Single-use bioreactor systems accounted for the largest share of single-use bioreactors market<\/strong><\/p>\n

Based on product, the single-use bioreactors market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes\/sensors, among others. The single-use bioreactor systems segment dominated the single-use bioreactors market in 2020. SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.<\/p>\n

Stirred-tank SUBs accounted for the largest share of single-use bioreactors market<\/strong><\/p>\n

Based on type, the single-use bioreactors market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs segment dominated the single-use bioreactors market in 2020. The stirred-tank SUBs are highly preferred in the cultivation of aerobic microbial cultures as it promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.<\/p>\n

The contract research organizations (CROs) and contract manufacturing organizations (CMOs) is the fastest-growing end user segment of the single-use bioreactors market<\/strong><\/p>\n

Based on end users, the single-use bioreactors market is segmented into pharmaceutical & biopharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), and academic & research institutes. The contract research organizations (CROs) and contract manufacturing organizations (CMOs) segment is projected to register the highest CAGR in the single-use bioreactors market during the forecast period. The increasing outsourcing of R&D and manufacturing services by pharmaceutical and biopharmaceutical companies is expected to support the growth of the CROs & CMOs segment.<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=49113750<\/a><\/p>\n

North America accounted for the largest share of the single-use bioreactors market<\/strong><\/p>\n

North America accounted for the largest share of the single-use bioreactors market, followed by Europe in 2020. The large share of the North American regional segment can be attributed to the presence of a well-established biopharmaceutical industry and major players operating in the single-use bioreactors market.<\/p>\n

The prominent players operating in the single-use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany).<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets<\/a>
Contact Person:<\/strong> Mr. Aashish Mehra
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL 60062
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/single-use-bioreactor-market-49113750.html<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the single-use bioreactors market. Single-use Bioreactors Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,417,412,406,416],"tags":[],"class_list":["post-570009","post","type-post","status-publish","format-standard","hentry","category-Business","category-Marketing-Sales","category-News-Current-Affairs","category-Pharmaceuticals-Biotech","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/570009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=570009"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/570009\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=570009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=570009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=570009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}